| Date | Speaker | Title | Time starts | Duration |
| November 2015 | Chris Kosmidis | Isavuconazole: a new antifungal drug | 0’00’00secs | 0’36’40secs |
| Graham Atherton | Patients and carers disucssion | 0’36’40secs | end | |
| Led by Graham Atherton | Entire meeting (alternate version) |
We had to switch off the discussion with patients after Chris & Graham’s introduction ending at 36min 40sec as the group had to proceed privately. The slides discussed give a good deal of the information we talked about so are well worth reading once the talking has stopped.
Resources mentioned:
Share this post
Latest News posts
How to use nebulised amphotericin
January 29, 2019
David Haussler: What Can We Learn From Sequencing Our Genomes?
January 29, 2019
Interview with CPA patient
January 29, 2019
Open the windows Poetry & Medicine
January 29, 2019
Bridging the Health Divide in Europe
January 29, 2019
Translational Medicine in Respiratory Disease
January 29, 2019
ERS Vision – Personalising Respiratory Care in Europe
January 29, 2019
Nutritional Science in the Prevention & Management of COPD
January 29, 2019
Designing Drugs to Better Help Real Lives
January 29, 2019
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video